Fuji Pharma Co., Ltd. (TYO:4554)

Fuji Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 15, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	32,367	30,950	28,337	25,121	28,416	38,917
Market Cap Growth	-18.94%	9.22%	12.80%	-11.60%	-26.98%	-5.14%
Enterprise Value	58,045	57,137	54,046	45,919	37,050	39,914
Last Close Price	1325.00	1255.03	1116.03	958.54	1047.76	1092.89
PE Ratio	10.15	5.04	8.25	9.32	11.68	18.67
Forward PE	8.98	7.24	8.29	8.47	12.03	20.48
PS Ratio	0.66	0.67	0.69	0.71	0.84	1.15
PB Ratio	0.71	0.68	0.69	0.70	0.87	0.97
P/TBV Ratio	0.96	0.94	0.92	0.99	0.94	1.05
P/FCF Ratio	6.26	22.54	-	-	12.89	11.29
P/OCF Ratio	4.81	7.46	14.78	-	4.74	6.75
PEG Ratio	-	1.12	1.12	1.12	1.12	1.12
EV/Sales Ratio	1.19	1.24	1.32	1.30	1.09	1.18
EV/EBITDA Ratio	6.67	7.56	7.85	7.04	6.79	7.68
EV/EBIT Ratio	12.24	14.72	14.01	12.15	11.06	12.71
EV/FCF Ratio	11.23	41.61	-	-	16.81	11.58
Debt / Equity Ratio	0.71	0.64	0.70	0.69	0.57	0.31
Debt / EBITDA Ratio	3.72	3.87	4.21	3.77	3.42	2.35
Debt / FCF Ratio	6.26	21.31	-	-	8.47	3.54
Asset Turnover	0.55	0.53	0.51	0.51	0.54	0.55
Inventory Turnover	1.35	1.51	1.39	1.50	1.70	1.77
Quick Ratio	0.79	0.66	0.63	0.68	1.10	2.16
Current Ratio	1.57	1.19	1.31	1.45	1.73	3.18
Return on Equity (ROE)	7.07%	14.17%	8.92%	7.87%	6.70%	5.26%
Return on Assets (ROA)	3.34%	2.77%	3.00%	3.38%	3.32%	3.20%
Return on Capital (ROIC)	3.97%	3.35%	3.70%	4.23%	4.04%	3.83%
Return on Capital Employed (ROCE)	7.60%	7.20%	6.90%	7.30%	7.60%	6.20%
Earnings Yield	9.81%	19.86%	12.12%	10.73%	8.56%	5.36%
FCF Yield	15.97%	4.44%	-4.98%	-22.91%	7.76%	8.86%
Dividend Yield	3.41%	3.39%	3.31%	3.65%	2.77%	2.65%
Payout Ratio	34.23%	15.82%	26.17%	27.04%	33.18%	43.36%
Buyback Yield / Dilution	-0.14%	-0.04%	-0.03%	9.58%	13.77%	-2.06%
Total Shareholder Return	3.26%	3.35%	3.28%	13.23%	16.54%	0.59%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.